Insider Trading History of Keson-brookes Maiken

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Keson-brookes Maiken since 2021. This trader's CIK number is 1693805. At the time of last reporting, Keson-brookes Maiken was the See Remarks of Mural Oncology Plc. (stock ticker symbol MURA). Also see all insider trading activities at Mural Oncology Plc.

Note that in the past Keson-Brookes Maiken also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Mural Oncology Plc (MURA) by Keson-brookes Maiken

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 MURA 0 $0 7,461 $21,037 0 $0
2024 MURA 0 $0 2,157 $7,355 0 $0

Yearly summary of insider trading at Rubius Therapeutics, Inc. (RUBY) by Keson-brookes Maiken

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 RUBY 0 $0 2,732 $17,957 8,075 $0
2021 RUBY 0 $0 25,000 $505,975 25,000 $192,500


Insider trading activities at 2 companies by Keson-brookes Maiken:

1. Mural Oncology Plc (MURA)

2. Rubius Therapeutics, Inc. (RUBY)

Table 1. Insider trading of Mural Oncology Plc (MURA) by Keson-brookes Maiken

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-07-22 MURA Sale 2,572 2.48 6,378
2025-07-18 MURA Sale 2,158 2.48 5,351
2025-03-05 MURA Sale 1,469 3.45 5,068
2025-03-04 MURA Sale 1,262 3.36 4,240
2024-07-18 MURA Sale 2,157 3.41 7,355

Table 2. Insider trading of Rubius Therapeutics, Inc. (RUBY) by Keson-brookes Maiken

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-02-01 RUBY Sale 2,732 6.57 17,957
2022-01-29 RUBY Option Ex 8,075 .00 0
2021-03-15 RUBY Sale 25,000 20.24 505,975
2021-03-15 RUBY Option Ex 25,000 7.70 192,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Keson-brookes Maiken (See Remarks of Mural Oncology Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.